People experiencing psoriasis and asthma receive PBS relief Patients with urea cycle disorder will also benefit from the new round of listings.
Australian drug prices low by world standards A new report has found Australians are paying among the lowest prices in the world for generic prescription drugs.
GP feedback requested for compliance audit With the Department of Health’s approach to health provider compliance under the microscope, GPs are seeking clarity to ensure they are adequately informed about their obligations.
MBS item changes to impact GPs GPs now have to update billing practices related to heart health assessments, telehealth consultations, eating disorders and colonoscopy.
Concerns over insurers’ push to fund GP visits Proponents have said it would help support under-pressure doctors, but public health advocates are worried it could lead to a two-tiered system.
New telehealth funding ‘a good start’ But the Chair of RACGP Rural believes fewer restrictions and further expansion is required to ensure every Australian can access quality healthcare.
Cystic fibrosis drug listed on PBS While the announcement was welcomed, some have questioned the seven month delay between approval and listing.
Pharmaceutical Benefits Advisory Council responds to criticism Chair Andrew Wilson said suggestions of delayed approvals are not new and Australia has one of ‘the fastest systems in the world’.
Questions raised over new crackdown on after-hours GP service A key health watchdog is investigating Australia’s largest after-hours GP service in the first ever inquiry into a company rather than individual doctors.
Use of general practice and enhanced primary care services rising Data on Medicare-subsidised health services shows Australians are visiting GPs more, with general practice representing one in three services used.